Business, Science, and Practice: Securing Next Generation Healthcare

24 May , 11:00–12:15
Human Capital in the Digital Economy
Panel Session
Pavilion F, Conference Hall F1

Cutting-edge technologies are crucial for achieving breakthroughs in the quality of healthcare and this complex endeavour will take up the coming 10–15 years. It requires choosing the right concept, competent researchers, modern laboratories, sustainable financing, and close cooperation with medical centres and patients. University teaching hospitals serve as the source of progressive ideas for the pharmaceutical industry and manufacturers of high-tech medical equipment. Implementing new ideas requires investment by both the public and private sectors and Russia has vast experience of collaborating with socially-oriented businesses to support science. Such collaboration is already advancing cancer treatment for children, the most vulnerable category of patients. It is vital that the results of the research belong to the public and thus are available to patients. Can financing R&D through non-profit funds ensure that new technologies are accessible to patients? How can we guarantee that new, expensive technologies become affordable to the majority of patients? What obstacles are medical scientists facing today? How are other countries promoting the development and introduction of innovative technologies? What is the role of the state in supporting innovative research and is investing in Russian R&D a charitable act or viable business for non-medical companies?

Evelina Zakamskaya, Editor-in-Chief, Doctor Channel; Anchor, Russia 24

Kevin Ali, President, MSD International
Boris Afanasyev, Director, Rаisa Gorbacheva Memorial Research Institute for Paediatric Oncology, Haematology and Transplantation
Mikhail Maschan, Director, Institute of Haematology, Immunology and Cell Technologies, Dmitry Rogachev National Research Centre of Paediatric Haematology, Oncology and Immunology
Javad Nazarian, Principal Investigator, Brain Tumour Institute, Children’s National Health System
Galina Novichkova, Chairperson of the Board, Foundation for Support and Development in Children’s Haematology, Oncology, and Immunology ‘Doctors, Innovations, Science for Children’
Sergey Tsyb, Deputy Minister of Industry and Trade of the Russian Federation
Jan-Willem Scheijgrond, Vice President, Global Head of Government and Public Affairs, Royal Philips
Tatyana Yakovleva, Deputy Minister of Healthcare of the Russian Federation

Front row participants
Dmitry Korobkov, Chairman of the Board of Directors, ADV
Jacky Ovadia, Director of International Medicine, Clalit Health Services
Mikhail Panteleev, Professor of the Department of Medical Physics, Faculty of Physics, Lomonosov Moscow State University